PedAM
Pediatric Disease Annotations & Medicines
| Disease | colorectal cancer |
| Symptom | C0007102|colon cancer |
| Sentences | 7 |
| PubMedID- 22562256 | Methods: one hundred seventy-eight stage ii colon cancers out of 682 colorectal cancer patients who underwent surgical resection were selected. |
| PubMedID- 23571142 | Prognostic role of p53 messenger ribonucleic acid expression in patients after curative resection for stage i to iii colorectal cancer: association with colon cancer stem cell markers. |
| PubMedID- 22108516 | Approximately 5% of colorectal cancers are associated with hereditary non-polyposis colon cancer, an inherited cancer predisposition syndrome caused by germ-line alteration of mismatch repair genes (mmr). |
| PubMedID- 25750795 | (2007)diabetes management, hemoglobin a1c, blood pressure, weight loss, total cholesterol, and hdlnareductions in hba1c, weight and cholesterol level, and significant improvement in hdl levels in the ig vs. cg (p = .001)chan and vernon (2008)colon cancer screeningnaviewing of netlet colorectal cancer screening electronic intervention: public internet access group = 1 of 11, private internet access group = 10 of 42; returned fobt kit: 11 of 42 (26%) private access ig and 8 of 35 (23%) private access cg (received physician reminder letter), no public access ig, and 3 out of 9 public access cgjoseph et al. |
| PubMedID- 26311139 | In order to help resolve these controversies, we conducted a retrospective study to evaluate the clinicopathologic features and clinical outcomes of taiwanese colorectal cancer (crc) patients with right colon cancer versus those with left colon cancer according to the various cancer stages. |
| PubMedID- 21483656 | The trial is titled swog 0820: “a double blind placebo-controlled trial of eflornithine and sulindac to prevent recurrence of high risk adenomas and second primary colorectal cancers in patients with stage 0-iii colon cancer, phase iii” (study coordinators: j. zell, p. |
| PubMedID- 20086113 | Genetic variation in the vitamin d receptor (vdr) and the vitamin d-binding protein (gc) and risk for colorectal cancer: results from the colon cancer family registry. |
Page: 1